Companies / Brazil
Unichem In Talks With Cimed
February 2007 | FDI AlertIndia's Unichem Laboratories is reportedly in talks with Brazilian drugmaker Cimed to acquire its São Paulo-based injectable drug unit, Neckerman. As BMI has already reported, Unichem has been in talks to acquire a distributor in Brazil, along with IP rights, such as existing marketing authorisations. Valor Economico quoted a senior manager at Cimed as saying that they are also discussing a distribution tie-up, on top of the deal to acquire Neckerman. The transaction could be worth as much as US$25mn.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
